Johnson & Johnson (jnj)
JNJ News
Live headlines and press releases for Johnson & Johnson load in the terminal.
Company news & press releases is available in Vest Terminal for Professional and Enterprise subscribers.
Start Free — open JNJ in Vest Terminal
Access live data, filings, ownership, and analysis for Johnson & Johnson.
Johnson & Johnson FAQ
What does Johnson & Johnson (JNJ) do?
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers produc…
What is JNJ's P/E ratio?
Johnson & Johnson has a trailing P/E of 31.26× based on publicly available market data.
Does JNJ pay a dividend?
Indicated dividend yield: 2.0%. Confirm ex-dates and payout history in Vest Terminal.
What sector is JNJ in?
Johnson & Johnson is classified in Healthcare (Drug Manufacturers - General) on NYQ.
What is JNJ's market capitalization?
Approximate market cap: $648.67B.
What are the main risks for JNJ?
Standard market, competitive, and execution risks apply; see the Risks section.
What are the strengths of JNJ?
Potential positives include revenue growth of 6.6% year-over-year, return on equity near 25.7% — efficient use of shareholder capital.
Where can I get analyst estimates for JNJ?
Public analyst price targets and consensus for Johnson & Johnson are on the free /stocks/jnj/estimates page. Deeper estimate history and models are available in Vest Terminal.